Filter by: patients
Home > Community Treatment Reports and Side Effects > Pioglitazone Treatment Report
What is Pioglitazone?

Pioglitazone is an oral diabetes medicine that help control blood sugar levels. It is for people with type 2 (non-insulin-dependent) diabetes and is sometimes used in combination with insulin or other medications, but it is not for treating type 1 diabetes. Brand name is Actos.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 52 11 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Other 7 2 Efficacy_moderate Efficacy_slight
Elevated blood sugar (hyperglycemia) 4 2 Efficacy_major Efficacy_slight
ALS (Amyotrophic Lateral Sclerosis) 4 4 Efficacy_cant_tell
High Cholesterol 2 0
Diabetes Type 1 2 0

See all 72 patients currently taking Pioglitazone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 4
Mild
 4
None
 10

Commonly reported side effects, conditions, and hospitalizations associated with Pioglitazone

Weight gain 6
Kidney damage 1
Future risk of lung cancer 1

Reported Dosages

  30mg as needed 10 mg daily 15 mg daily 30 mg daily 45 mg daily 60 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 18 Number of Patients: 18 27 Number of Patients: 27 26 Number of Patients: 26 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Pioglitazone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 6   Doctor's advice: 35%
Side effects too severe 5   Side effects too severe: 29%
Personal research 4   Personal research: 24%
Course of treatment ended 3   Course of treatment ended: 18%
Did not seem to work 2   Did not seem to work: 12%
Expense 1   Expense: 6%
Other 1   Other: 6%

See all 16 patients who’ve stopped taking Pioglitazone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Pioglitazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Pioglitazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Pioglitazone

Always
 16 84%
Usually
 3 16%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Pioglitazone

Very
 0 0%
Somewhat
 0 0%
A little
 3 16%
Not at all
 16 84%

Cost

Paid out of pocket

Cost of Pioglitazone

$200+
 1 7%
$100-199
 0 0%
$50-99
 1 7%
$25-49
 3 20%
< $25
 10 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.